gefitinib has been researched along with Carcinoma, Lewis Lung in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PC; Guo, CH; Hsia, S; Lee, SY; Li, WC; Peng, CL | 1 |
| Hsia, S; Wang, H; Wu, CJ; Wu, TH | 1 |
| Ding, L; He, QJ; Liang, GK; Tariq, M; Yang, B; Zhang, JQ | 1 |
| Chen, W; Dong, B; Li, C; Li, G; Li, R; Niu, M; Qi, S; Shi, Y; Wang, R; Zhang, M; Zhou, XW | 1 |
| Kawahara, K; Maeda, T; Watanabe, S; Yamada, D | 1 |
| Maruyama, S; Sukegawa, Y; Yagita, A | 1 |
6 other study(ies) available for gefitinib and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Targeting EGFR in Combination with Nutritional Supplements on Antitumor Efficacy in a Lung Cancer Mouse Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Dietary Supplements; ErbB Receptors; Erlotinib Hydrochloride; Fish Oils; Gefitinib; Glycogen Synthase Kinase 3 beta; Mice; Protein Kinase Inhibitors; Selenium | 2022 |
Fish Oil, Se Yeast, and Micronutrient-Enriched Nutrition as Adjuvant Treatment during Target Therapy in a Murine Model of Lung Cancer.
Topics: Administration, Oral; Animals; Apoptosis; Cachexia; Carcinoma, Lewis Lung; Cell Line, Tumor; Chemotherapy, Adjuvant; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fish Oils; Gefitinib; Inflammation; Male; Mice, Inbred C57BL; Micronutrients; Neoplasm Metastasis; Oxidation-Reduction; Protein Kinase Inhibitors; Selenium; Sunitinib; Tumor Burden; Yeast, Dried | 2021 |
Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Movement; Cell Plasticity; Cell Proliferation; Dose-Response Relationship, Drug; Gefitinib; Interleukin-13; Macrophages; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Phenotype; Protein Kinase Inhibitors; Quinazolines; RAW 264.7 Cells; Signal Transduction; STAT6 Transcription Factor | 2017 |
The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Gefitinib; Lung Neoplasms; Male; Medicine, Chinese Traditional; Metabolomics; Mice; Mice, Inbred C57BL | 2019 |
Plexin A1 signaling confers malignant phenotypes in lung cancer cells.
Topics: Animals; Apoptosis; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Erlotinib Hydrochloride; Gefitinib; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glucose; Mice; Nerve Tissue Proteins; Protein Kinase Inhibitors; Quinazolines; Receptors, Cell Surface; RNA, Small Interfering; Semaphorin-3A; Signal Transduction | 2016 |
[Significance of gefitinib combined with immunotherapy in tumor-bearing mice].
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; ErbB Receptors; Gefitinib; Immunotherapy; Interleukin-12; Mice; Quinazolines | 2003 |